These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 15902486

  • 1. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
    Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M.
    Virchows Arch; 2005 Jun; 446(6):589-95. PubMed ID: 15902486
    [Abstract] [Full Text] [Related]

  • 2. BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
    Trovisco V, Vieira de Castro I, Soares P, Máximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M.
    J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508
    [Abstract] [Full Text] [Related]

  • 3. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
    Musholt PB, Musholt TJ, Morgenstern SC, Worm K, Sheu SY, Schmid KW.
    World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
    [Abstract] [Full Text] [Related]

  • 4. A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.
    Trovisco V, Soares P, Soares R, Magalhães J, Sá-Couto P, Sobrinho-Simões M.
    Hum Pathol; 2005 Jun; 36(6):694-7. PubMed ID: 16021577
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status.
    Abrosimov A, Saenko V, Rogounovitch T, Namba H, Lushnikov E, Mitsutake N, Yamashita S.
    Int J Cancer; 2007 Jan 01; 120(1):196-200. PubMed ID: 17044028
    [Abstract] [Full Text] [Related]

  • 7. Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.
    Lee X, Gao M, Ji Y, Yu Y, Feng Y, Li Y, Zhang Y, Cheng W, Zhao W.
    Ann Surg Oncol; 2009 Feb 01; 16(2):240-5. PubMed ID: 19034577
    [Abstract] [Full Text] [Related]

  • 8. Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA).
    Sapio MR, Posca D, Troncone G, Pettinato G, Palombini L, Rossi G, Fenzi G, Vitale M.
    Eur J Endocrinol; 2006 Feb 01; 154(2):341-8. PubMed ID: 16452550
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.
    Afkhami M, Karunamurthy A, Chiosea S, Nikiforova MN, Seethala R, Nikiforov YE, Coyne C.
    Thyroid; 2016 Feb 01; 26(2):242-7. PubMed ID: 26422023
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Expression of BRAF V600E mutation in different thyroid lesions].
    Wang W, Li XH, Zhang YH, Li J, Chen J, Zhao P, Li QY, Xiang JJ, Li X, Xu RJ.
    Zhonghua Zhong Liu Za Zhi; 2011 May 01; 33(5):354-7. PubMed ID: 21875464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma.
    Kim TY, Kim WB, Song JY, Rhee YS, Gong G, Cho YM, Kim SY, Kim SC, Hong SJ, Shong YK.
    Clin Endocrinol (Oxf); 2005 Nov 01; 63(5):588-93. PubMed ID: 16268813
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single center.
    Lim JY, Hong SW, Lee YS, Kim BW, Park CS, Chang HS, Cho JY.
    Thyroid; 2013 Nov 01; 23(11):1423-30. PubMed ID: 23496275
    [Abstract] [Full Text] [Related]

  • 16. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.
    Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G, Elisei R, Santoro M, Miccoli P, Basolo F.
    J Clin Endocrinol Metab; 2007 Nov 01; 92(11):4085-90. PubMed ID: 17785355
    [Abstract] [Full Text] [Related]

  • 17. Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.
    Kowalska A, Walczyk A, Kowalik A, Pałyga I, Trybek T, Kopczyński J, Kajor M, Chrapek M, Pięciak L, Chłopek M, Góźdź S, Kamiński G.
    Thyroid; 2016 Apr 01; 26(4):543-51. PubMed ID: 26889698
    [Abstract] [Full Text] [Related]

  • 18. BRAF mutations in an Italian cohort of thyroid cancers.
    Fugazzola L, Mannavola D, Cirello V, Vannucchi G, Muzza M, Vicentini L, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2004 Aug 01; 61(2):239-43. PubMed ID: 15272920
    [Abstract] [Full Text] [Related]

  • 19. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAFV600E Mutation.
    Lee SE, Hwang TS, Choi YL, Kim WY, Han HS, Lim SD, Kim WS, Yoo YB, Kim SK.
    Thyroid; 2017 Jun 01; 27(6):802-810. PubMed ID: 28293988
    [Abstract] [Full Text] [Related]

  • 20. BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.
    Chakraborty A, Narkar A, Mukhopadhyaya R, Kane S, D'Cruz A, Rajan MG.
    Endocr Pathol; 2012 Jun 01; 23(2):83-93. PubMed ID: 22105775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.